At a glance
ClinicalIndex Comparison RecordN/ACompleted· 385 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Subtherapeutic Heparin Anticoagulation as a Predictor of Recurrent Venous Thromboembolism: A Population-Based Cohort Study
In Brief
An observational study for Cardiovascular Diseases and Thromboembolism. Completed, enrolled 385 participants across 1 site.
Detailed Summary
To evaluate the trends in the incidence of venous thromboembolism, to determine the risk factors for venous thromboembolism in patients with medical and surgical illness, and to evaluate the efficacy of the anticoagulant therapy in reducing venous thromboembolism.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCardiovascular Diseases, Thromboembolism
CountriesUnited States
CollaboratorsNational Heart, Lung, and Blood Institute (NHLBI)
Timeline
N/ACompletedFinished
200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedFeb 2001
Enrollment StartApr 2001
Primary CompletionMay 2009
TodayJul 2026
First PostedFeb 13, 2001
Enrollment StartApr 1, 2001
Primary CompletionMay 1, 2009
TodayJul 2, 2026
Enrollment to primary: 8.1 yearsPosted 25.4 years ago